tiprankstipranks
AbCellera Biologics Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsAbCellera Biologics Reports Q3 2024 Financial Results
3M ago
AbCellera Biologics Expands Partnership and Advances Pipeline
Premium
Company Announcements
AbCellera Biologics Expands Partnership and Advances Pipeline
3M ago
AbCellera reports Q3 EPS (17c), consensus (15c)
Premium
The Fly
AbCellera reports Q3 EPS (17c), consensus (15c)
3M ago
AbCellera expands collaboration with Eli Lilly
PremiumThe FlyAbCellera expands collaboration with Eli Lilly
6M ago
AbCellera price target lowered to $5 from $7 at KeyBanc
Premium
The Fly
AbCellera price target lowered to $5 from $7 at KeyBanc
7M ago
AbCellera management to meet with KeyBanc
Premium
The Fly
AbCellera management to meet with KeyBanc
9M ago
AbCellera management to meet with Truist
PremiumThe FlyAbCellera management to meet with Truist
10M ago
AbCellera management to meet with Truist
Premium
The Fly
AbCellera management to meet with Truist
10M ago
AbCellera gets upfront payment for collaboration with Biogen for antibodies
Premium
The Fly
AbCellera gets upfront payment for collaboration with Biogen for antibodies
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100